The UroMonitor, a wireless, insertable pressure sensor to assist in the diagnosis of urinary incontinence and other bladder disorders, is safe, feasible and well-tolerated in women with refractory overactive bladder, according to clinical trial data reported in the Journal of Urology.
Urologists at Cleveland Clinic have found a new application for machine learning within their field, and they’re using it to improve shared decision making in the treatment of a common urologic diagnosis: overactive bladder.
A wireless, insertable pressure sensor to assist in the diagnosis of urinary incontinence and other bladder disorders is safe, feasible and well-tolerated in women with refractory overactive bladder.
Findings from a new study reinforce the safety and acceptability of laparoscopic sacrocolpopexy as an outpatient procedure.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A scarcity of resources in the time of COVID-19 has led to new considerations around essential and nonessential care in subspeciality fields. Cleveland Clinic urologists recently published recommendations on how to prioritize care for urologic patients. They also offer insight on how to implement the system at your own institution.
This ‘fitness tracker for the bladder,’ now in preclinical testing, has the potential to eliminate the need for urodynamics and the discomfort and inconvenience it entails.
Does routine preoperative medical evaluation before radical prostatectomy justify the time and cost involved? New research reveals the impact of this type of evaluation on perioperative management and surgical outcomes.
Cleveland Clinic urologists evaluate the latest OAB interventions, from nerve stimulation to radiofrequency ablation.
Transobturator slings for incontinence in rare cases can cause intractable groin or thigh pain in some women. Cleveland Clinic urologists evaluated thigh dissection with mesh removal and found it improved outcomes.
Cleveland Clinic is now a participant in the American Urological Association’s Quality Registry (AQUA), a national urologic disease registry that measures and reports healthcare quality and patient outcomes. Howard Goldman, MD, the Glickman Urological & Kidney Institute’s Vice Chairman for Quality, explains how the AQUA registry works, and how taking part benefits physicians and patients.